Viking Therapeutics Inc Earnings

The next earnings date for Viking Therapeutics Inc is February 11, 2026.

They are scheduled to announce earnings after the market closes that day.

Analyst Estimates of Viking Therapeutics Inc Earnings

Report DateEstimated Earnings Per Share
02/11/2026$-0.75

What is an Earnings Date

An earnings date is typically considered to be the date that a company publicly announces its earnings. Many companies in the US stock market do earnings announcements once per quarter.

Earnings announcements are typically accompanied by commentary from the company that explains the earnings performance and speaks to future earnings prospects.

Earnings announcements can cause a company’s stock price to change abruptly, so earnings dates are closely monitored by some investors.

Viking Therapeutics Inc Earnings: Historical

Report DateBefore/After MarketEarnings Per ShareSurprise %
10/22/2025After Market$0100.00%
07/22/2025Before Market------
04/22/2025Before Market$-0.41-31.71%
02/05/2025After Market$-0.32-14.29%
10/23/2024After Market$-0.2212.00%
07/24/2024After Market$-0.2025.93%
04/24/2024After Market$-0.267.14%
02/07/2024After Market$-0.250.00%
10/25/2023After Market$-0.23-4.55%
07/26/2023After Market$-0.190.00%
04/26/2023After Market$-0.25-4.17%
02/08/2023After Market$-0.26-13.04%
10/26/2022After Market$-0.218.70%
07/27/2022After Market$-0.23-9.52%
04/27/2022After Market$-0.21-10.53%
02/09/2022After Market$-0.1615.79%
11/03/2021After Market$-0.1719.05%
07/28/2021After Market$-0.200.00%
04/28/2021After Market$-0.19-11.76%
02/17/2021After Market$-0.150.00%
10/28/2020After Market$-0.1313.33%
07/29/2020After Market$-0.137.14%
04/30/2020After Market$-0.13-8.33%
02/26/2020After Market$-0.1023.08%
11/05/2019Before Market$-0.0838.46%
08/01/2019After Market$-0.11-22.22%
05/02/2019After Market$-0.0722.22%
03/13/2019After Market$-0.0730.00%
11/07/2018After Market$-0.118.33%
08/09/2018After Market$-0.13-18.18%
05/09/2018After Market$-0.0833.33%
03/07/2018After Market$-0.1417.65%
11/08/2017After Market$-0.22-10.00%
08/09/2017After Market$-0.21-5.00%
05/10/2017After Market$-0.23-35.29%
03/21/2017After Market$-0.1810.00%
11/10/2016After Market$-0.204.76%
08/10/2016Before Market$-0.22-10.00%
05/10/2016After Market$-0.4016.67%
03/08/2016After Market$-0.56-30.23%
11/05/2015Before Market$-0.53-65.63%
08/13/2015Before Market$-1.07-723.08%
06/11/2015After Market$-1.40-600.00%

More About Viking Therapeutics Inc

Country
USA
Full Time Employees
50

Viking Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development of novel therapies for metabolic and endocrine disorders. The company's lead drug candidate is VK2809, an orally available tissue and receptor-subtype selective agonist of the thyroid hormone receptor beta (TRß), which is in Phase IIb clinical trials to treat patients with biopsy-confirmed non-alcoholic steatohepatitis, as well as NAFLD. It develops VK5211, an orally available non-steroidal selective androgen receptor modulator that is in Phase II clinical trials for the treatment of patients recovering from non-elective hip fracture surgery; VK0612, an orally available Phase IIb-ready drug candidate for type 2 diabetes; VK2735, a novel dual agonist of the glucagon-like peptide, which is in Phase 1 SAD/MAD clinical trial, and VK0214, an orally available tissue and receptor-subtype selective agonist of the TRß for X-linked adrenoleukodystrophy. The company was incorporated in 2012 and is headquartered in San Diego, California.

Viking Therapeutics Inc Earnings” Can Refer to the Viking Therapeutics Inc Earnings Date

Some people say “Viking Therapeutics Inc earnings” as a shortform way to refer to the earnings date.

For example, someone might say, “I plan to hold my Viking Therapeutics Inc position through earnings.” That typically means the person is going to hold their position through the upcoming earnings date.

Owning Viking Therapeutics Inc Stock on the Earnings Date

If you own Viking Therapeutics Inc stock (VKTX) on the earnings date, then you will be exposed to the potential price volatility that often accompanies earnings announcements.

A company’s earnings typically have a big impact on its stock price, which explains why the stock price for Viking Therapeutics Inc might exhibit major fluctuations on the day of the earnings announcement. The price fluctuations can go in either direction (up or down), representing a larger potential investment risk and reward than many other days of the year.

There is often a big audience of investors involved with trading Viking Therapeutics Inc shares of stock on its earnings day. This means there is typically more trading volume, liquidity, and price volatility on the day earnings are announced.

These features are attractive to some types of active traders who are looking for stocks that exhibit large price movements and substantial volume.

Owning Viking Therapeutics Inc Options on the Earnings Date

If you own Viking Therapeutics Inc options on the earnings date, then you will be exposed to the potential price volatility that often accompanies earnings announcements.

In addition, the extrinsic values of Viking Therapeutics Inc options that overlap earnings dates are often higher than other days of the year. In other words, the premiums you pay to own Viking Therapeutics Inc options are typically higher during that period. In particular, they are frequently higher immediately before earnings and on the day they’re announced.

This makes sense considering that prices are often more volatile on earnings dates for Viking Therapeutics Inc. That potential volatility is a key factor that affects the premium cost of owning options.

Once the earnings announcement is done and the anticipated price volatility has gone down, the extrinsic values of Viking Therapeutics Inc options often go down. This is sometimes referred to as volatility crush.

Learning More Viking Therapeutics Inc Earnings

You can contact us any time if you would like to ask questions about Viking Therapeutics Inc earnings or anything else related to the stock market.